Dong-Youn Hwang

Prof. Dr. Dong-Youn Hwang


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2010 in Stem Cell Reviews and Reports
Verified
Journal Article
Closed access
PDF file
DKDae-Sung Kim
Dae-Sung Kim
JLJae Souk Lee
Jae Souk Lee
JLJoong Woo Leem
Joong Woo Leem
YHYong Jun Huh
Yong Jun Huh
JKJi Young Kim
Ji Young Kim
DKDong-Wook Kim
Dong-Wook Kim

18 February 2013 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
JYJongman Yoo
Jongman Yoo
HKHan‐Soo Kim
Han‐Soo Kim
DHDong-Youn Hwang
Dong-Youn Hwang

1 August 2017 in Stem Cell Reports
Verified
Journal Article
Open access
JJJiho Jang
Jiho Jang
YHYong Jun Huh
Yong Jun Huh
HCHyun-Ju Cho
Hyun-Ju Cho
BLBo Ram Lee
Bo Ram Lee
JPJaepil Park
Jaepil Park
DKDong-Wook Kim
Dong-Wook Kim
Human embryonic stem cells (hESCs) hold great promise for the treatment of many incurable diseases. Sirtuin1 (SIRT1), a class III histone deacetylase, is abundantly expressed in hESCs and is known to regulate early differentiation and telomere elongation. Here, we show that downregulation of SIRT1 promotes cell death in hESCs, but not in differentiated cells, and the SIRT1-inhibition-mediated cell death is preceded by increased DNA damage. This increased DNA damage is at least partially due to decreased levels of DNA repair enzymes such as MSH2, MSH6, and APEX1. Furthermore, SIRT1 inhibition causes p53 activation, which eventually leads to DNA damage-induced apoptosis of hESCs. This study provides valuable insights into the mechanism of SIRT1-mediated hESC survival and should contribute to the development of safe and effective cell therapies.

4 November 2009 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
DHDong-Youn Hwang
Dong-Youn Hwang
SHSunghoi Hong
Sunghoi Hong
JJJoo‐Won Jeong
Joo‐Won Jeong
SCSangdun Choi
Sangdun Choi
HKHansoo Kim
Hansoo Kim
KKKwang‐Soo Kim
Kwang‐Soo Kim
Midbrain dopamine (mDA) neurons play critical roles in the regulation of voluntary movement and their dysfunction is associated with Parkinson’s disease. Pitx3 has been implicated in the proper development of mDA neurons in the substantia nigra pars compacta, which are selectively lost in Parkinson’s disease. However, the basic mechanisms underlying its role in mDA neuron development and/or survival are poorly understood. Toward this goal, we sought to identify downstream target genes of Pitx3 by comparing gene expression profiles in mDA neurons of wild‐type and Pitx3‐deficient aphakia mice. This global gene expression analysis revealed many potential target genes of Pitx3; in particular, the expression of vesicular monoamine transporter 2 and dopamine transporter, responsible for dopamine storage and reuptake, respectively, is greatly reduced in mDA neurons by Pitx3 ablation. In addition, gain‐of‐function analyses and chromatin immunoprecipitation strongly indicate that Pitx3 may directly activate transcription of vesicular monoamine transporter 2 and dopamine transporter genes, critically contributing to neurotransmission and/or survival of mDA neurons. As the two genes have been known to be regulated by Nurr1, another key dopaminergic transcription factor, we propose that Pitx3 and Nurr1 may coordinately regulate mDA specification and survival, at least in part, through a merging and overlapping downstream pathway.

11 December 2009 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
DHDong-Youn Hwang
Dong-Youn Hwang
DKDae‐Sung Kim
Dae‐Sung Kim
DKDong-Wook Kim
Dong-Wook Kim

24 June 2015 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
JOJinsoo Oh
Jinsoo Oh
KLKang-In Lee
Kang-In Lee
HKHyeong-Taek Kim
Hyeong-Taek Kim
YYYoungsang You
Youngsang You
DYDo Heum Yoon
Do Heum Yoon
DHDong-Youn Hwang
Dong-Youn Hwang
Introduction: Induced pluripotent stem cells (iPSCs) have emerged as a promising cell source for immune-compatible cell therapy. Although a variety of somatic cells have been tried for iPSC generation, it is still of great interest to test new cell types, especially those which are hardly obtainable in a normal situation. Methods: In this study, we generated iPSCs by using the cells originated from intervertebral disc which were removed during a spinal operation after spinal cord injury. We investigated the pluripotency of disc cell-derived iPSCs (diPSCs) and neural differentiation capability as well as therapeutic effect in spinal cord injury. Results: The diPSCs displayed similar characteristics to human embryonic stem cells and were efficiently differentiated into neural precursor cells (NPCs) with the capability of differentiation into mature neurons in vitro. When the diPSC-derived NPCs were transplanted into mice 9 days after spinal cord injury, we detected a significant amelioration of hindlimb dysfunction during follow-up recovery periods. Histological analysis at 5 weeks after transplantation identified undifferentiated human NPCs (Nestin+) as well as early (Tuj1+) and mature (MAP2+) neurons derived from the transplanted NPCs. Furthermore, NPC transplantation demonstrated a preventive effect on spinal cord degeneration resulting from the secondary injury. Conclusion: This study revealed that intervertebral discs removed during surgery for spinal stabilization after spinal cord injury, previously considered a “waste” tissue, may provide a unique opportunity to study iPSCs derived from difficult-to-access somatic cells and a useful therapeutic resource for autologous cell replacement therapy in spinal cord injury.